General MedicationsTOPICALGeneric
SILDAFLO
SILVER SULFADIAZINE
Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview SILDAFLO is listed in Drugs@FDA under application 019608 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient SILVER SULFADIAZINE Form and strength DRESSING;TOPICAL - 1% Sponsor FRANKLIN PHARMS Submission history Latest submission status date: 2000-02-25 00:00:00.
Structured Monograph
Clinical summary
Approval overview SILDAFLO is listed in Drugs@FDA under application 019608 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SILVER SULFADIAZINE Form and strength DRESSING;TOPICAL - 1% Sponsor FRANKLIN PHARMS Submission history Latest submission status date: 2000-02-25 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.